Remove Medical Remove Pharmaceutical Remove Therapy
article thumbnail

Get to Know Alys Pharmaceuticals, Inc.

The Dermatology Digest

Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. ” The post Get to Know Alys Pharmaceuticals, Inc.

article thumbnail

Ligand Pharmaceuticals Launches Pelthos to Accelerate Commercialization of Zelsuvmi for Molluscum; Appoints New CEO

The Dermatology Digest

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Zelsuvmi received a Novel Drug designation from the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

article thumbnail

Benefits of the Trigger Point Massage

Hollywood Institute

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Curious if , massage therapy is the right solution for your chronic pain? What is Trigger Point Therapy? What are the Benefits of Trigger Point Therapy?

Therapy 52
article thumbnail

Topline Results: Verrica’s VP-315 Performs Well in BCC Trial

The Dermatology Digest

Verrica Pharmaceuticals Inc.’s The Company also plans to submit the final Phase 2 data for presentation at future medical meetings. s VP-315 is showing promise in the treatment of basal cell carcinoma, according to Part 2 of its Phase 2 clinical trial.

Safety 36
article thumbnail

Chronic and Mysterious Symptoms May Be Autoimmunity and can take years to diagnose

Aesthetics Advisor

Most medical schools still only teach how to identify late-stage autoimmune disease, not how to identify autoimmunity in its early stages and nor how to affect its progression through dietary, nutritional, pharmaceutical, or lifestyle applications. Every supplement and every therapy is a shot in the dark.

article thumbnail

Fenbendazole Joe Tippens Protocol: A Simple Step-by-Step Guide (2023)

Aesthetics Advisor

Disclaimer: We in no way endorse the Joe Tippens Cancer Protocol as a cure for cancer, and as always, you should consult your physician before starting any new medications or treatment plans. Curcumin may help increase healthy p53 levels, and it has been shown to be a potentially effective cancer therapy supplement.

Therapy 69